Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage Lung Cancer-A Done Deal?

被引：7
|
作者：
Gulstene, S. [1 ]
Ruwanpura, T. [2 ]
Palma, D. [1 ]
Joseph, N. [3 ]
机构：
[1] London Hlth Sci Ctr, Dept Radiat Oncol, London, ON, Canada
[2] Christie NHS Fdn Trust, Manchester, England
[3] Minist Hlth, Colombo, Sri Lanka
来源：
CLINICAL ONCOLOGY | 2022年 / 34卷 / 11期
关键词：
Early -stage lung cancer; lung cancer; non -small cell lung cancer; NSCLC; SABR; SBRT; BODY RADIATION-THERAPY; TUMORS; SABR; PNEUMONITIS; DISEASE; SBRT; VALIDATION; RECURRENCE; PREDICTION; EXPERIENCE;
D O I：
10.1016/j.clon.2022.08.027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Stereotactic ablative radiotherapy (SABR) is an important curative-intent treatment option for early-stage non-small cell lung cancer. It offers good cancer control without invasive surgery and has become the standard of care for medically inoperable patients. The literature on SABR for early-stage non-small cell lung cancer is substantial and continues to grow. However, there remain areas of controversy where data are limited -notably the use of SABR in medically operable patients. Other areas of some debate include the treatment of central/ultra-central and large (>5 cm) lesions, as well as treatment with co-existing interstitial lung disease. This review article provides an overview of the current literature together with a discussion of future directions.(c) 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：733 / 740
页数：8
相关论文
共 50 条
  • [21] Stereotactic ablative radiotherapy for medically inoperable early stage lung cancer: early outcomes
    Chan, Oscar S. H.
    Yeung, Rebecca M. W.
    Hung, Albert W. M.
    Lee, Michael C. H.
    Chang, Amy T. Y.
    Chan, Connie C. C.
    Lee, Anne W. M.
    HONG KONG MEDICAL JOURNAL, 2012, 18 (05) : 412 - 418
  • [22] Proton-Based Stereotactic Ablative Radiotherapy in Early-Stage Non-Small-Cell Lung Cancer
    Grant, Jonathan D.
    Chang, Joe Y.
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [23] Is microwave ablation an alternative to stereotactic ablative body radiotherapy in patients with inoperable early-stage primary lung cancer?
    Watson, Robert A.
    Tol, Isabel
    Gunawardana, Shannon
    Tsakok, Maria T.
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2019, 29 (04) : 539 - 543
  • [24] Stereotactic Ablative Radiotherapy for Early-stage Lung Cancer in Patients With Left Ventricular Assist Device: A Case Series
    Hayashi, Kazuhiko
    Ishikawa, Hiroshi
    Fujiwara, Kei
    Nakai, Masataka
    Ono, Hitoshi
    Fumimoto, Yasutoshi
    Tamaki, Nobuyuki
    Tatekawa, Shotaro
    Hirata, Takero
    Kimura, Toru
    Hirata, Haruhiko
    Tamari, Keisuke
    Takeda, Yoshito
    Shimizu, Shinichi
    Shintani, Yasushi
    Ogawa, Kazuhiko
    ANTICANCER RESEARCH, 2024, 44 (09) : 4113 - 4117
  • [25] Stereotactic Ablative Radiotherapy Induces Peripheral T-Cell Activation in Patients with Early-Stage Lung Cancer
    de Goeje, Pauline L.
    Smit, Egbert F.
    Waasdorp, Cynthia
    Schram, Merel T. B.
    Kaijen-Lambers, Margaretha E. H.
    Bezemer, Koen
    de Mol, Mark
    Hartemink, Koen J.
    Nuyttens, Joost J. M. E.
    Maat, Alexander P. W. M.
    Hegmans, Joost P. J. J.
    Hendriks, Rudi W.
    Senan, Suresh
    Aerts, Joachim G. J. V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (09) : 1224 - 1227
  • [26] STEREOTACTIC ABLATIVE BODY RADIOTHERAPY VERSUS ABLATION FOR THE TREATMENT OF EARLY-STAGE HEPATOCELLULAR CARCINOMA
    Egan, Darragh
    Mohammadi, Fadak
    Andersson, Lauren
    Ormiston, William
    Tibballs, Jonathan
    Samuelson, Shaun
    Van Wyk, Matthys
    Clifford, Matthew
    Bertot, Luis Calzadilla
    Le, Hien
    Wallace, Michael
    Wigg, Alan
    HEPATOLOGY, 2024, 80
  • [27] Stereotactic ablative body radiotherapy versus ablation for the treatment of early-stage hepatocellular carcinoma
    Egan, Darragh
    Mohammadi, Fadak
    Andersson, Lauren
    Ormiston, William
    Tibballs, Jonathan
    Samuelson, Shaun
    Van Wyk, Matthys
    Clifford, Matthew
    Bertot, Luis Calzadilla
    Le, Hien
    Tang, Colin
    Wallace, Michael
    Wigg, Alan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 93 - 93
  • [28] Definitive treatment of early-stage non-small cell lung cancer with stereotactic ablative body radiotherapy in a community cancer center setting
    Heal, Cory
    Ding, William
    Lamond, John
    Wong, Michael
    Lanciano, Rachelle
    Su, Stacy
    Yang, Jun
    Feng, Jing
    Arrigo, Stephen
    Markiewicz, Deborah
    Hanlon, Alexandra
    Brady, Luther
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [29] Treatment of Early Stage Non-Small Cell Lung Cancer: Surgery or Stereotactic Ablative Radiotherapy?
    Uzel, Esengul Kocak
    Abacioglu, Ufuk
    BALKAN MEDICAL JOURNAL, 2015, 32 (01) : 8 - 16
  • [30] Stereotactic ablative radiotherapy for early-stage central lung tumors: status, challenges, and future considerations
    Li, Ming
    Zhan, Cheng
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
12345